Based on 1 analysts giving stock ratings to Surgepays Inc in the past month.
In the current month, SURG has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SURG average Analyst price target in the last month is 3.750.
Based on analysts' estimates, SURG EPS is projected to reach -0.070 in FY2026Q3, following reported EPS of 0.050 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.05, while Surgepays IncSURG's earnings per share (EPS) for the previous quarter was USD -0.51. EPS for the next quarter is expected at USD -0.07.